998 related articles for article (PubMed ID: 9297994)
1. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
[TBL] [Abstract][Full Text] [Related]
2. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
Staessen JA; Fagard R; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene MR; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A
Arch Intern Med; 1998 Aug 10-24; 158(15):1681-91. PubMed ID: 9701103
[TBL] [Abstract][Full Text] [Related]
3. Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.
Staessen JA; Thijs L; Celis H; Gasowski J; Wang JG; Fagard RH;
S Afr Med J; 2001 Dec; 91(12):1060-8. PubMed ID: 11845604
[TBL] [Abstract][Full Text] [Related]
4. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.
Liu L; Wang JG; Gong L; Liu G; Staessen JA
J Hypertens; 1998 Dec; 16(12 Pt 1):1823-9. PubMed ID: 9869017
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
[TBL] [Abstract][Full Text] [Related]
6. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
Forette F; Seux ML; Staessen JA; Thijs L; Babarskiene MR; Babeanu S; Bossini A; Fagard R; Gil-Extremera B; Laks T; Kobalava Z; Sarti C; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Birkenhäger WH;
Arch Intern Med; 2002 Oct; 162(18):2046-52. PubMed ID: 12374512
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive therapy in older patients with isolated systolic hypertension: the Syst-Eur experience in general practice. The Syst-Eur Investigators.
Celis H; Yodfat Y; Thijs L; Clement D; Cozic J; De Cort P; Forette F; Grégoire M; Heyrman J; Stibbe G; Van den Haute M; Staessen J; Fagard R
Fam Pract; 1996 Apr; 13(2):138-43. PubMed ID: 8732324
[TBL] [Abstract][Full Text] [Related]
8. Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Fagard RH; Staessen JA
Clin Exp Hypertens; 1999; 21(5-6):491-7. PubMed ID: 10423075
[TBL] [Abstract][Full Text] [Related]
9. Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; de Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y
J Hum Hypertens; 1999 Feb; 13(2):135-45. PubMed ID: 10100063
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension.
Staessen JA; Thijs L; Fagard RH; Birkenhäger WH; Arabidze G; Babeanu S; Gil-Extremera B; Bulpitt CJ; Davidson C; de Leeuw PW; Efstratopoulos AD; Fletcher AE; Fogari R; Jääskivi M; Kawecka-Jaszcz K; Nachev C; Petrie JC; Seux ML; Tuomilehto J; Webster J; Yodfat Y
Hypertension; 1998 Sep; 32(3):410-6. PubMed ID: 9740604
[TBL] [Abstract][Full Text] [Related]
11. Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial.
Staessen JA; Thijs L; Gasowski J; Cells H; Fagard RH
Am J Cardiol; 1998 Nov; 82(9B):20R-22R. PubMed ID: 9822139
[TBL] [Abstract][Full Text] [Related]
12. Syst-Eur--a multicenter trial on the treatment of isolated systolic hypertension in the elderly: first interim report.
Staessen J; Amery A; Birkenhäger W; Bulpitt CJ; Cox J; de Leeuw P; De Cort P; Fagard R; Fletcher A; Forette F
J Cardiovasc Pharmacol; 1992 Jan; 19(1):120-5. PubMed ID: 1375678
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; de Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R;
J Hypertens; 2001 Mar; 19(3):511-9. PubMed ID: 11288822
[TBL] [Abstract][Full Text] [Related]
14. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.
Forette F; Seux ML; Staessen JA; Thijs L; Birkenhäger WH; Babarskiene MR; Babeanu S; Bossini A; Gil-Extremera B; Girerd X; Laks T; Lilov E; Moisseyev V; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Fagard R
Lancet; 1998 Oct; 352(9137):1347-51. PubMed ID: 9802273
[TBL] [Abstract][Full Text] [Related]
15. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.
Staessen JA; Thijisq L; Fagard R; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Forette F; Leonetti G; McCormack P; Nachev C; O'Brien E; Rodicio JL; Rosenfeld J; Sarti C; Tuomilehto J; Webster J; Yodfat Y; Zanchetti A;
J Hypertens; 2004 Apr; 22(4):847-57. PubMed ID: 15126928
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial.
Thijs L; Richart T; de Leeuw PW; Kuznetsova T; Grodzicki T; Kawecka-Jaszcz K; O'Brien E; Redón J; Birkenhäger WH; Fagard R; Staessen JA
J Hypertens; 2010 Apr; 28(4):865-74. PubMed ID: 20051905
[TBL] [Abstract][Full Text] [Related]
17. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.
Wang JG; Staessen JA; Gong L; Liu L
Arch Intern Med; 2000 Jan; 160(2):211-20. PubMed ID: 10647760
[TBL] [Abstract][Full Text] [Related]
18. Therapy in old patients with isolated systolic hypertension: fourth progress report on the Syst-Eur trial.
Antikainen R; Tuomilehto J; Thijs L; Vanhanen H; Sarti C; Birkenhäger W; Arabidze G; Fagard R; Grigorow M; Jankulova K; Jääskivi M; Kohonen-Jalonen P; Laks T; Lazebnic L; Mantova S; Nachev C; Kermova P; Vänskä O; Yodfat Y; Bulpitt CJ; Staessen JA
J Hum Hypertens; 1997 May; 11(5):263-9. PubMed ID: 9205931
[TBL] [Abstract][Full Text] [Related]
19. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
[TBL] [Abstract][Full Text] [Related]
20. Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial.
Staessen J; Bert P; Bulpitt C; De Cort P; Fagard R; Fletcher A; Kivinen P; Lehtomaki E; Leonetti G; O'Brien E
J Hum Hypertens; 1993 Jun; 7(3):265-71. PubMed ID: 8345494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
